» Authors » J J Badimon

J J Badimon

Explore the profile of J J Badimon including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 184
Citations 3538
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Sirtori C, Ruscica M, Calabresi L, Chiesa G, Giovannoni R, Badimon J
Ann Med . 2019 Nov; 51(7-8):345-359. PMID: 31729238
Epidemiologically, high-density lipoprotein (HDL) cholesterol levels have been inversely associated to cardiovascular (CV) events, although a Mendelian Randomisation Study had failed to establish a clear causal role. Numerous atheroprotective mechanisms...
2.
Sabatel-Perez F, Garcia-Ropero A, Santos-Gallego C, Urooj Zafar M, Badimon J
Drugs Today (Barc) . 2019 May; 55(5):329-344. PMID: 31131843
Atherosclerotic cardiovascular disease is the leading cause of death all over the world. Its etiopathogenesis involves many correlated processes, with hypercholesterolemia being one of the main risk factors. Several large...
3.
Garcia-Ropero A, Santos-Gallego C, Zafar M, Badimon J
Drugs Today (Barc) . 2019 Apr; 55(3):197-214. PMID: 30938374
The number of patients receiving dual antiplatelet therapy with an additional indication for long-term oral anticoagulation has substantially increased over time. This population is facing an unacceptable risk of bleeding...
4.
Zafar M, Badimon J, Escolar G
J Thromb Haemost . 2018 Jan; 16(3):605-606. PMID: 29314712
No abstract available.
5.
Siniawski D, Santos-Gallego C, Badimon J, Masson W
Acta Cardiol . 2016 Sep; 71(4):463-72. PMID: 27594363
No abstract available.
6.
Falk E, Fallon J, Mailhac A, Fernandez-Ortiz A, Meyer B, Weng D, et al.
Cardiovasc Pathol . 2015 May; 3(3):183-9. PMID: 25990995
The reliability of a rabbit polyclonal antibody against muramidase to identify monocytes/macrophages in swine was evaluated by immunostaining of cell smears and formaldehyde-fixed, paraffin-embedded tissue sections. Blood in tissue sections,...
7.
Barrios V, Escobar C, Llisterri J, Rodriguez Roca G, Badimon J, Vergara J, et al.
Semergen . 2014 Dec; 41(1):3-12. PMID: 25459384
Aims: To determine the prevalence and incidence of cardiovascular risk factors and cardiovascular events in Spain, as well as the quality of the follow-up in clinical practice. In this study...
8.
Zafar M, Santos-Gallego C, Vorchheimer D, Viles-Gonzalez J, Elmariah S, Giannarelli C, et al.
J Thromb Haemost . 2012 Nov; 11(1):100-6. PMID: 23137352
Background: Hemostatic benefits of platelet transfusions in thienopyridine-treated acute coronary syndrome (ACS) patients may be compromised by residual metabolite in circulation. Objectives: To estimate the earliest time after a prasugrel...
9.
Giannarelli C, Cimmino G, Ibanez B, Chiesa G, Garcia-Prieto J, Santos-Gallego C, et al.
Thromb Haemost . 2012 Oct; 108(6):1246-8. PMID: 23093000
No abstract available.
10.
Becker E, Perzborn E, Klipp A, Lucker C, Butehorn U, Kast R, et al.
J Thromb Haemost . 2012 Oct; 10(12):2470-80. PMID: 23083002
Background: Despite standard dual antiplatelet therapy (DAT) (acetylsalicylic acid [ASA] and clopidogrel), there is a ≥ 1.4% incidence of in-stent thrombosis in patients with acute coronary syndrome. Factor Xa inhibitors...